Inactive Instrument

Company Amoy Diagnostics Co Ltd Shenzhen S.E.

Equities

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
- CNY - Intraday chart for Amoy Diagnostics Co Ltd

Business Summary

Amoy Diagnostics Co Ltd is a pharmaceutical company engaged in research, development, production and sales of molecular diagnostic products. The Company provides testing reagents and testing services for tumor diagnosis. The Company’s testing reagent products include ADx-ARMS product line for tumor tissue specimen detection, Super-ARMS product line for liquid biopsy, the NGS product line and the FISH product line. The products are used for the detection of non-small cell lung cancer, colorectal cancer, thyroid cancer, melanoma and other malignant tumors. The Company also provides data software to capture and analyze gene sequencing data. The Company provides testing services through its own medical testing institutions, including lung cancer testing, colorectal cancer testing and breast cancer testing.

Sales per Business

CNY in Million2022Weight2023Weight Delta
Detection Reagents
82.4 %
611 72.6 % 860 82.4 % +40.64%
Drug Clinical Research Services
8.5 %
86 10.2 % 89 8.5 % +3.10%
Testing Services
8.1 %
135 16.0 % 85 8.1 % -37.09%
Other
1.0 %
10 1.2 % 10 1.0 % +2.42%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
81.2 %
697 82.8 % 847 81.2 % +21.54%
Overseas
18.8 %
145 17.2 % 196 18.8 % +35.27%

Managers

Managers TitleAgeSince
Chief Executive Officer 41 31/12/11
Founder 71 20/02/08
Director of Finance/CFO 54 31/03/15
Chairman 40 31/05/10
Director/Board Member 34 31/12/16
Director/Board Member 46 31/07/09
Investor Relations Contact - -
Corporate Officer/Principal 62 30/06/11

Members of the board

Members of the board TitleAgeSince
Founder 71 20/02/08
Chief Executive Officer 41 31/12/11
Director/Board Member 76 17/06/15
Director/Board Member 47 31/03/17
Chairman 40 31/05/10
Director/Board Member 34 31/12/16
Director/Board Member 69 29/09/21
Director/Board Member 68 29/09/21
Director/Board Member 79 12/08/21
Director/Board Member 42 30/04/10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 402,929,809 257,034,570 ( 63.79 %) 4,389,500 ( 1.089 %) 63.79 %

Shareholders

NameEquities%Valuation
87,701,616 22.06 % 265 M ¥
Xiamen Yixiang Investment Partnership LP
5.038 %
20,026,900 5.038 % 61 M ¥
19,866,146 4.997 % 60 M ¥
Harvest Fund Management Co., Ltd.
4.494 %
17,866,370 4.494 % 54 M ¥
8,642,433 2.174 % 26 M ¥
Xiamen Haicang Rundingsheng Investment LP
1.827 %
7,264,926 1.827 % 22 M ¥
6,237,438 1.569 % 19 M ¥
ICBC Credit Suisse Asset Management Co., Ltd.
1.239 %
4,924,430 1.239 % 15 M ¥
3,531,226 0.8882 % 11 M ¥
Da Cheng Fund Management Co., Ltd.
0.8302 %
3,300,560 0.8302 % 10 M ¥

Holdings

NameEquities%Valuation
3,531,226 0.89% 8,969,420 $

Company contact information

Amoy Diagnostics Co., Ltd.

39 Dingshan Road Haicang District

361027, Xiamen

+

http://www.amoydx.com
address Amoy Diagnostics Co Ltd
  1. Stock Market
  2. Equities
  3. 300685 Stock
  4. Stock
  5. Company Amoy Diagnostics Co Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW